- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Selective Androgen Receptor Modulator (SARM) · Educational Resource
Understanding LGD-4033 and Muscle Tissue Research
Selective Androgen Receptor Modulator
(Non-Steroidal SARM)
Investigational Application
Muscle, bone tissue research
Administration Protocol
Oral, per study protocol
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Selective Androgen Receptor Modulator (SARM) · Educational Resource
Understanding LGD-4033 and Muscle Tissue Research
01 — Overview
What is LGD-4033?
LGD-4033 is a synthetic, non-steroidal compound classified as a selective androgen receptor modulator (SARM), studied for its tissue-selective binding properties.
As an investigational compound, LGD-4033 has not received regulatory approval for therapeutic use in the Philippines or elsewhere, and it is not approved for use in competitive sport.
Within research literature, LGD-4033 is most frequently studied for its relationship to lean body mass and bone density parameters, areas summarized further below.
02 — How it works
How It Works: Selective Androgen Receptor Activation in Muscle and Bone Tissue
As a selective androgen receptor modulator, LGD-4033 is studied for its ability to bind androgen receptors with reported tissue selectivity, engaging muscle and bone tissue receptors while researchers report comparatively less activity in other androgen-sensitive tissues.
Literature describes this selectivity as the key distinguishing feature researchers associate with the SARM compound class, relative to traditional anabolic-androgenic steroid compounds.
Administration in Research
In clinical literature, LGD-4033 is evaluated primarily via oral administration within controlled research protocols. As an investigational compound, it has not received regulatory approval for therapeutic use, and research contexts differ from any at-home or self-directed use.
03 — Areas of research
Summary of Investigated Research Areas
Clinical literature evaluates LGD-4033 across several key physiological parameters to map its biological interactions:
Selective Receptor Binding Pathways
Research literature evaluates how LGD-4033 is studied for its selective binding to androgen receptors in muscle and bone tissue, with comparatively less activity studied in other tissues.
Lean Body Mass Studies
Clinical studies observe lean body mass measures following LGD-4033 administration in controlled research settings.
Bone Density Parameters
Investigational literature examines bone mineral density markers associated with SARM-class compound exposure.
Hormonal Suppression Markers
Studies explore endogenous hormone level changes observed during LGD-4033 administration in clinical trial settings.
Muscle Strength Research
Some literature investigates muscle strength parameters tracked over controlled study periods.
Pharmacokinetic Profiling
Studies characterize the oral bioavailability and elimination profile of LGD-4033 in clinical research.
04 — FAQ
Frequently Asked Questions
Ano ba talaga ang LGD-4033?
Ang LGD-4033 ay isang non-steroidal compound na selective androgen receptor modulator (SARM). Pinag-aaralan ito sa research dahil sa tissue-selective binding nito sa muscle at bone tissue. Educational discussion lang ito, hindi sales o medical advice.
FDA-approved ba ito?
Hindi. Ang LGD-4033 ay hindi FDA-approved at hindi rin pinapayagan gamitin sa competitive sports. Fully investigational compound pa rin ito.
Ano ang ibig sabihin ng "selective" sa SARM?
Tumutukoy ito sa pag-aaral ng compound na may mas nakatuong binding sa muscle at bone receptors kumpara sa ibang tissues, na kaiba sa traditional na anabolic steroids.
Pwede ba akong bumili nito dito?
Ang page na ito ay para sa educational purposes lamang. Hindi kami nagbebenta ng compounds dito online — kausapin ang isang lisensyadong healthcare provider para sa tamang gabay.
05 — References
References and Academic Literature
Basaria, S., et al. (2013). The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men. The Journals of Gerontology: Series A.
Van Wagoner, R.M., et al. (2017). Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet. JAMA.
Solomon, Z.J., et al. (2019). Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sexual Medicine Reviews.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups